These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16389410)

  • 1. Antibiotic therapy for coronary heart disease: The myth and the reality.
    Kuppuswamy VC; Gupta S
    Drugs Today (Barc); 2005 Oct; 41(10):677-85. PubMed ID: 16389410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic therapy for coronary heart disease: the myth and the reality.
    Kuppuswamy VC; Gupta S
    Timely Top Med Cardiovasc Dis; 2006 Jan; 10():E2. PubMed ID: 16404482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there an infective aetiology to atherosclerosis?
    Gupta S; Camm AJ
    Drugs Aging; 1998 Jul; 13(1):1-7. PubMed ID: 9679204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlamydia pneumoniae, antimicrobial therapy and coronary heart disease: a critical overview.
    Gupta S; Camm AJ
    Coron Artery Dis; 1998; 9(6):339-43. PubMed ID: 9812184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic infection in the aetiology of atherosclerosis--focus on Chlamydia pneumoniae.
    Gupta S
    Atherosclerosis; 1999 Mar; 143(1):1-6. PubMed ID: 10208475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlamydia pneumoniae and anti-infective therapy: their role in the pathogenesis and treatment of coronary artery disease.
    Behbahani R; Verme-Gibboney C; Romanelli AM
    Clin Ther; 1999 Aug; 21(8):1286-300; discussion 1285. PubMed ID: 10485501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic therapy in coronary heart disease--where do we currently stand?
    Anand V; Gupta S
    Cardiovasc Drugs Ther; 2001; 15(3):209-10. PubMed ID: 11713887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic trials for coronary heart disease.
    Anderson JL; Muhlestein JB
    Tex Heart Inst J; 2004; 31(1):33-8. PubMed ID: 15061624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlamydia pneumoniae and atherosclerosis -- what we know and what we don't.
    Ngeh J; Anand V; Gupta S
    Clin Microbiol Infect; 2002 Jan; 8(1):2-13. PubMed ID: 11906495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study.
    Anderson JL; Muhlestein JB; Carlquist J; Allen A; Trehan S; Nielson C; Hall S; Brady J; Egger M; Horne B; Lim T
    Circulation; 1999 Mar; 99(12):1540-7. PubMed ID: 10096928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of Chlamydia pneumoniae in the pathogenesis of coronary disease].
    Kähler J; Köster R; Bräser JH; Schäfer P; Terres W; Hamm CW; Meinertz T
    Z Kardiol; 1999 Nov; 88(11):885-95. PubMed ID: 10643056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlamydia pneumoniae and coronary heart disease.
    Carlisle SS; Nahata MC
    Ann Pharmacother; 1999 May; 33(5):615-22. PubMed ID: 10369627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Infective Chlamydia pneumoniae and coronary disease: where is the truth?].
    Malinverni R
    Rev Med Suisse Romande; 2000 Jan; 120(1):43-6. PubMed ID: 10705790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease.
    Kalayoglu MV; Libby P; Byrne GI
    JAMA; 2002 Dec; 288(21):2724-31. PubMed ID: 12460096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale and design of a secondary prevention trial of antibiotic use in patients after myocardial infarction: the WIZARD (weekly intervention with zithromax [azithromycin] for atherosclerosis and its related disorders) trial.
    Dunne MW
    J Infect Dis; 2000 Jun; 181 Suppl 3():S572-8. PubMed ID: 10839762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Description and status of the azithromycin and coronary events study (ACES).
    Jackson LA
    J Infect Dis; 2000 Jun; 181 Suppl 3():S579-81. PubMed ID: 10839763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging concepts in disease management: a role for antimicrobial therapy in coronary artery disease.
    Girard SE; Temesgen Z
    Expert Opin Pharmacother; 2001 May; 2(5):765-72. PubMed ID: 11336621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Atherosclerosis and Chlamydia pneumoniae].
    Larsen MM; Mørn B; Andersen PL; Østergaard LJ
    Ugeskr Laeger; 2002 Dec; 164(50):5920-4. PubMed ID: 12553110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlamydia pneumoniae and coronary artery disease: the antibiotic trials.
    Higgins JP
    Mayo Clin Proc; 2003 Mar; 78(3):321-32. PubMed ID: 12630585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arteriosclerosis caused by infection? A possible link between Chlamydia pneumoniae and atherosclerosis].
    Persson K; Boman J
    Lakartidningen; 1998 May; 95(20):2334-6, 2339-40. PubMed ID: 9630800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.